No quarterly revenue total was found in StimCell Energetics Inc.'s SEC filings.
StimCell Energetics Inc. (STME) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus.
Revenue
—
Net income
$-169,518
+36.2% vs year-ago quarter
Operating cash flow
$-108,995
-0.8% vs year-ago quarter
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
21.14M
+2.4% vs year-ago quarter
Net cash
—
Operating margin
—
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- STME (OTC)
- Fiscal year ends
- May 31
- Incorporated in
- NV
- Headquarters
- Vancouver, British Columbia, Canada
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1493712
- Former names
- Cell MedX Corp. (until Oct 15, 2024); Sports Asylum, Inc. (until Oct 9, 2014); Plandel Resources, Inc. (until Mar 24, 2014)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q1 FY2027 Aug 31, 2026 |
Q4 FY2026 May 31, 2026 |
Q3 FY2026 Feb 28, 2026 |
Q2 FY2026 Nov 30, 2025 |
Q1 FY2026 Aug 31, 2025 |
|---|---|---|---|---|---|
| Net income | -$169,518 | -$229,459 | -$90,566 | -$309,748 | -$265,602 |
| Operating cash flow | -$108,995 | -$43,511 | -$86,290 | -$74,138 | -$108,142 |
| Total assets | $60,946 | $81,454 | $34,521 | $52,345 | $16,387 |
| Total liabilities | $2.0M | $1.9M | $1.7M | $1.6M | $1.4M |
| Stockholders' equity | -$2.0M | -$1.8M | -$1.7M | -$1.5M | -$1.4M |
| Cash and investments | $6,883 | $3,057 | $10,257 | $46,159 | $6,437 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 14, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 8, 2026 | Aug 24, 2026 |
| 10-K | Annual report | Aug 31, 2026 | May 31, 2026 |
| 10-Q | Quarterly report | Apr 10, 2026 | Feb 28, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Mar 20, 2026 | Mar 12, 2026 |
| 10-Q | Quarterly report | Jan 15, 2026 | Nov 30, 2025 |
All 273 StimCell Energetics Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.